Eva Roblegg
Has grant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Development of advanced structures via 3D-printing for pharmaceutical inserts and implants
Open Date: 2022-01-01
Close Date: 2025-01-01
Grant: Close
Active organotypic models for nanoparticle toxicological screening
Open Date: 2019-08-01
Close Date: 2023-07-31
Grant: Close
Pharmacokinetic profiling of silver nanoparticles: the role of biological barriers
Open Date: 2018-01-01
Close Date: 2019-12-01
Grant: Close
Rationale Formulierungsentwicklung zur Steigerung die Wirksamkeit, Sicherheit und der Qualität von Arzneimitteln
Open Date: 2018-01-01
Close Date:
Grant: Close
Entwicklung und Charakterisierung von druckbaren Nanosuspensionen zur buccalen Anwendung
Open Date: 2013-09-01
Close Date: 2016-11-01
Articles (10)
Year:
2023
Year:
2023
Year:
2023
The exposure to inhaled carbon nanotubes (CNT) may have adverse effects on workers upon chronic exposure. In order to assess the toxicity of inhaled nanoparticles in a physiologically relevant manner, an air–liquid interface culture of mono and cocultures of respiratory cells and assessment in reconstructed bronchial and alveolar tissues was used. The effect of CNT4003 reference particles applied in simulated lung fluid was studied in bronchial (Calu-3 cells, EpiAirway™ and MucilAir™ tissues) and alveolar (A549 +/−THP-1 and EpiAlveolar™ +/−THP-1) models. Cytotoxicity, transepithelial electrical resistance, interleukin 6 and 8 secretion, mucociliary clearance and ciliary beating frequency were used as readout parameters. With the exception of increased secretion of interleukin 6 in the EpiAlveolar™ tissues, no adverse effects of CNT4003 particles, applied at doses corresponding to the maximum estimated lifetime exposure of workers, in the bronchial and alveolar models were noted, suggesting no marked differences between the models. Since the doses for whole-life exposure were applied over a shorter time, it is not clear if the interleukin 6 increase in the EpiAlveolar™ tissues has physiological relevance.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (6)
Reingard Raml
deputy head of reserch group
Joanneum Research
Elisabeth Fink
Research Center Pharmaceutical Engineering GmbH
Peter Banzer
Full profesor and team leader
Graz University of Technology
Michael Grimm
University of Greifswald
Werner Weitschies
Professor of Biopharmaceutics
University of Greifswald
Eleonore Fröhlich
Medical University of Graz
Make your next move.
Prepare your application
Review drafts before you send them.